The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus
Open accessAbstract
A novel β-lactamase inhibitor has been isolated from Streptomyces clavuligerus ATCC 27064 and given the name clavulanic acid. Conditions for the cultivation of the organism and detection and isolation of clavulanic acid are described. This compound resembles the nucleus of a penicillin but differs in having no acylamino side chain, having oxygen instead of sulfur, and containing a β-hydroxyethylidine substituent in the oxazolidine ring. Clavulanic acid is a potent inhibitor of many β-lactamases, including those found in Escherichia coli (plasmid mediated), Klebsiella aerogenes, Proteus mirabilis , and Staphylococcus aureus , the inhibition being of a progressive type. The cephalosporinase type of β-lactamase found in Pseudomonas aeruginosa and Enterobacter cloacae P99 and the chromosomally mediated β-lactamase of E. coli are less well inhibited. The minimum inhibitory concentrations of ampicillin and cephaloridine against β-lactamase-producing, penicillin-resistant strains of S. aureus, K. aerogenes, P. mirabilis , and E. coli have been shown to be considerably reduced by the addition of low concentrations of clavulanic acid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naturally-occurring beta-lactamase inhibitors with antibacterial activity
BROWN, A. G., BUTTERWORTH, D., COLE, M., HANSCOMB, G., HOOD, J. D., READING, C., & ROLINSON, G. N. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.668 · Cited by 399
Self-citation.beta.-Lactam antibiotics from Streptomyces
Nagarajan, R., Boeck, L. D., Gorman, M., Hamill, R. L., Higgens, C. E., Hoehn, M. M., Stark, W. M., & Whitney, J. G. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a035 · Cited by 271
Cephalosporinase and penicillinase activities of a β-lactamase from Pseudomonas pyocyanea
Sabath, L., Jago, M., & Abraham, E. (1965) · Biochemical Journal · doi:10.1042/bj0960739 · Cited by 190
Howarth, T. T., Brown, A. G., & King, T. J. (1976) · J. Chem. Soc., Chem. Commun. · doi:10.1039/c3976000266b · Cited by 162
Streptomyces clavuligerus sp. nov., a -Lactam Antibiotic Producer
HIGGENS, C. E., & KASTNER, R. E. (1971) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-21-4-326 · Cited by 112
Whitney, J. G., BRANNON, D. R., MABE, J. A., & Wicker, K. J. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.1.3.247 · Cited by 54
Cole, M., Elson, S. W., & Fullbrook, P. D. (1972) · Biochemical Journal · doi:10.1042/bj1270295 · Cited by 40
Self-citationSTUDIES ON PENICILLINASE INHIBITORS PRODUCED BY MICROORGANISMS
Hata, T., Ōmura, S., IWAI, Y., Ohno, H., Takeshima, H., & YAMAGUCHI, N. (1972) · The Journal of Antibiotics · doi:10.7164/antibiotics.25.473 · Cited by 28
Cited by
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Natural product discovery: past, present, and future
Katz, L., & Baltz, R. H. (2016) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-015-1723-5 · Cited by 1,144
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Tooke, C. L., Hinchliffe, P., Bragginton, E. C., Colenso, C. K., Hirvonen, V. H. A., Takebayashi, Y., & Spencer, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.002 · Cited by 1,016
Past and Present Perspectives on β-Lactamases
Bush, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-18 · Cited by 832
Multidrug evolutionary strategies to reverse antibiotic resistance
Baym, M., Stone, L. K., & Kishony, R. (2016) · Science · doi:10.1126/science.aad3292 · Cited by 710
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Wright, G. D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.009 · Cited by 604
Industrial production of β-lactam antibiotics
Elander, R. P. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1274-y · Cited by 559
Interplay between β-lactamases and new β-lactamase inhibitors
Bush, K., & Bradford, P. A. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0159-8 · Cited by 531
The Evolution and Ecology of Bacterial Warfare
Granato, E. T., Meiller-Legrand, T. A., & Foster, K. R. (2019) · Current Biology · doi:10.1016/j.cub.2019.04.024 · Cited by 531
Targeting Antibiotic Resistance
Chellat, M. F., Raguž, L., & Riedl, R. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201506818 · Cited by 487
A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens
Song, M., Liu, Y., Huang, X., Ding, S., Wang, Y., Shen, J., & Zhu, K. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0723-z · Cited by 484
High-order species interactions shape ecosystem diversity
Bairey, E., Kelsic, E. D., & Kishony, R. (2016) · Nature Communications · doi:10.1038/ncomms12285 · Cited by 448
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Oxidative Cyclization in Natural Product Biosynthesis
Tang, M.-C., Zou, Y., Watanabe, K., Walsh, C. T., & Tang, Y. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00478 · Cited by 425
Herzberg, O., & Moult, J. (1987) · Science · doi:10.1126/science.3107125 · Cited by 351
Antibiotics in the clinical pipeline at the end of 2015
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2016.72 · Cited by 349
The Genotypic View of Social Interactions in Microbial Communities
Mitri, S., & Richard Foster, K. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-111212-133307 · Cited by 297
Envelope Structures of Gram-Positive Bacteria
Rajagopal, M., & Walker, S. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2015_5021 · Cited by 292
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
Huttner, A., Bielicki, J., Clements, M. N., Frimodt-Møller, N., Muller, A. E., Paccaud, J.-P., & Mouton, J. W. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.028 · Cited by 270
Bahr, G., González, L. J., & Vila, A. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00138 · Cited by 266
Antibiotics in the clinical pipeline in October 2019
Butler, M. S., & Paterson, D. L. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0291-8 · Cited by 264
Antibiotic adjuvants – A strategy to unlock bacterial resistance to antibiotics
González-Bello, C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.027 · Cited by 254
White, A. R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh050 · Cited by 198
Introduction: historical perspective and development of amoxicillin/clavulanate
Geddes, A. M., Klugman, K. P., & Rolinson, G. N. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.07.015 · Cited by 96
Ser, H.-L., Law, J. W.-F., Chaiyakunapruk, N., Jacob, S. A., Palanisamy, U. D., Chan, K.-G., Goh, B.-H., & Lee, L.-H. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00522 · Cited by 104
Page, M. G. P. (2012) · Antibiotic Discovery and Development · doi:10.1007/978-1-4614-1400-1_3 · Cited by 84
Utilization of ornithine and arginine as specific precursors of clavulanic acid
Romero, J., Liras, P., & Martín, J. F. (1986) · Applied and Environmental Microbiology · doi:10.1128/aem.52.4.892-897.1986 · Cited by 74
Rosa, J. C., Neto, A. B., Hokka, C. O., & Badino, A. C. (2005) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-004-0386-9 · Cited by 68
Utilization of soybean derivatives on clavulanic acid production by Streptomyces clavuligerus
Ortiz, S. C. A., Hokka, C. O., & Badino, A. C. (2007) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2006.08.009 · Cited by 50
Manipulation of the physiology of clavulanic acid production in Streptomyces clavuligerus
Ives, P. R., & Bushell, M. E. (1997) · Microbiology · doi:10.1099/00221287-143-11-3573 · Cited by 50
Kirk, S., Avignone-Rossa, C. A., & Bushell, M. E. (2000) · Biotechnology Letters · doi:10.1023/a:1005670603596 · Cited by 50
Wang, Y.-H., Yang, B., Ren, J., Dong, M.-L., Liang, D., & Xu, A.-L. (2005) · Process Biochemistry · doi:10.1016/j.procbio.2004.04.010 · Cited by 45
Teodoro, J. C., Baptista-Neto, A., Cruz-Hernández, I. L., Hokka, C. O., & Badino, A. C. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0273-6 · Cited by 42
Bushell, M. E., Kirk, S., Zhao, H.-J., & Avignone-Rossa, C. A. (2006) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2006.01.017 · Cited by 39
Maranesi, G. L., Baptista-Neto, A., Hokka, C. O., & Badino, A. C. (2005) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-004-2393-z · Cited by 37
Lynch, H. C., & Yang, Y. (2004) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2003.08.003 · Cited by 35
Garcia-Dominguez, M., Martin, J. F., & Liras, P. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.12.6808-6814.1989 · Cited by 33
Optimisation of medium composition for clavulanic acid production by Streptomyces clavuligerus
Gouveia, E. R., Baptista-Neto, A., Badino Jr, A. C., & Hokka, C. O. (2001) · Biotechnology Letters · doi:10.1023/a:1010356231673 · Cited by 31
Cerri, M. O., & Badino, A. C. (2012) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-012-0682-8 · Cited by 28
Gouveia, E. R., Baptista-Neto, A., Azevedo, A. G., Badino, A. C., & Hokka, C. O. (1999) · World Journal of Microbiology and Biotechnology · doi:10.1023/a:1008942405378 · Cited by 26
Clavulanic Acid Decomposition Is Catalyzed by the Compound Itself and by Its Decomposition Products
Brethauer, S., Held, M., & Panke, S. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21225 · Cited by 21
KIM, S.-J., KIM, J.-O., SHIN, C.-H., PARK, H. W., & KIM, C.-W. (2009) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.80569 · Cited by 15
Marques, D. A. V., Oliveira, R. P. S., Perego, P., Porto, A. L. F., Pessoa, A., & Converti, A. (2009) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2009.03.005 · Cited by 11
de Munnik, M., Calvopiña, K., Rabe, P., & Schofield, C. J. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00126-25 · Cited by 1
Metadata
- Authors
- Reading, C., & Cole, M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1977-05
- Volume
- 11
- Issue
- 5
- Pages
- 852-857
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2088021352
- Cited by
- 739
- References
- 8
- FWCI
- 12.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.